[17] This pattern of effects on microtubule stabilization is distinct from that of other clinically important tubulin-targeting agents, which include taxanes, epothilones, and vinca alkaloids.

Epothilones represent a new class of compounds with proven activity targeting the microtubules in breast cancer and appear capable of overcoming taxane resistance. ABI-007 is a novel formulation ...